First Trust Advisors LP Increases Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

First Trust Advisors LP boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 88.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 151,536 shares of the biotechnology company’s stock after acquiring an additional 71,087 shares during the quarter. First Trust Advisors LP’s holdings in Axon Enterprise were worth $90,061,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of AXON. Asset Dedication LLC boosted its stake in shares of Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after purchasing an additional 18 shares during the period. Bleakley Financial Group LLC lifted its holdings in Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after buying an additional 20 shares in the last quarter. Venturi Wealth Management LLC boosted its position in Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after buying an additional 21 shares during the last quarter. Burns Matteson Capital Management LLC grew its stake in shares of Axon Enterprise by 3.4% during the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock valued at $450,000 after acquiring an additional 25 shares in the last quarter. Finally, Transcend Capital Advisors LLC increased its position in shares of Axon Enterprise by 3.6% during the fourth quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company’s stock worth $431,000 after acquiring an additional 25 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Down 2.2 %

NASDAQ:AXON opened at $559.53 on Monday. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a 50 day simple moving average of $556.27 and a 200 day simple moving average of $567.52. The firm has a market capitalization of $42.87 billion, a P/E ratio of 144.58, a P/E/G ratio of 5.17 and a beta of 1.13.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on AXON shares. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Finally, Needham & Company LLC restated a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $626.45.

Insider Activity

In other news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.